"Welcome To Peachtree Dermatology. Board-certified dermatologists, Dr. Sturm, Dr. Wright, and Dr. Law each bring something unique to our patients with their own talents and specialties. At our Atlanta dermatology practice, the physicians and staff are some of the most respected skincare professionals in the region, and we believe everyone deserves healthy, beautiful skin. From managing chronic conditions to refining your complexion, let Peachtree Dermatology Associates be your source for optimal skin health. We treat all ages, from newborns to patients 99+ years young."

During the past decade, Peachtree Dermatology Associates Research Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Peachtree Dermatology Associates Research Center" #1 sponsor was "Braintree Laboratories" with 2 trials, followed by "LEO Pharma" with 2 trials sponsored, "Abbott" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Astellas Pharma Inc" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

According to Clinical.Site data, the most researched conditions in "Peachtree Dermatology Associates Research Center" are "Psoriasis" (4 trials), "Acne Vulgaris" (2 trials), "Cutaneous Lupus Erythematosus" (1 trials), "Psoriasis Vulgaris" (1 trials) and "Scalp Psoriasis" (1 trials). Many other conditions were trialed in "Peachtree Dermatology Associates Research Center" in a lesser frequency.

Most popular intervention types in "Peachtree Dermatology Associates Research Center" are "Drug" (9 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "BLI1100" (2 trials), "Placebo" (2 trials), "Alefacept exposure" (1 trials), "BLI1100 - modified formulation" (1 trials) and "Betamethasone-17,21-dipropionate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Peachtree Dermatology Associates Research Center" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Peachtree Dermatology Associates Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Peachtree Dermatology Associates Research Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Peachtree Dermatology Associates Research Center, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".